United States · FDA National Drug Code directory
Sertraline hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-205_4ec654e4-0bd5-934d-e063-6294a90a218d
- Product NDC
- 70010-205
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sertraline hydrochloride
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230515
- Source listing expiry
- 20271231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (70010-205-01) · 70010-205-01
- 30 TABLET, FILM COATED in 1 BOTTLE (70010-205-03) · 70010-205-03
- 500 TABLET, FILM COATED in 1 BOTTLE (70010-205-05) · 70010-205-05
- 90 TABLET, FILM COATED in 1 BOTTLE (70010-205-09) · 70010-205-09
- 1000 TABLET, FILM COATED in 1 BOTTLE (70010-205-10) · 70010-205-10
- 3000 TABLET, FILM COATED in 1 BOTTLE (70010-205-53) · 70010-205-53
- 8 BLISTER PACK in 1 CARTON (70010-205-63) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 70010-205-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →